Liver-associated enzymes

1. Berberine ursodeoxycholate decreases liver-associated enzymes in humans.

   “reductions in liver-associated enzymes”

   Human trialpresumed non-alcoholic steatohepatitis and type 2 diabetesliver1000 mg twice a day18 weeks

   A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes

   Nature communications·Sep 17, 2021

More on Berberine ursodeoxycholate